GE HealthCare Technologies Inc.
GEHC
Classement en actions
#771
GE HealthCare Technologies Inc. is a global medical technology company that... GE HealthCare Technologies Inc. is a global medical technology company that creates, manufactures, and markets a diverse range of medical devices, services, and integrated digital solutions. These offerings are designed to assist in the diagnosis, treatment, and ongoing monitoring of patients. The company boasts an extensive international presence, serving markets across the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, and Hong Kong, among other regions. Its operations are structured across four primary business divisions: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging division specializes in advanced diagnostic imaging technologies, including systems for molecular imaging, Computed Tomography (CT) scans, Magnetic Resonance (MR) imaging, image-guided therapy, and X-ray, alongside specialized women's health products. The Ultrasound segment delivers a comprehensive suite of ultrasound solutions utilized for the screening, diagnosis, treatment, and monitoring of various diseases. These applications span radiology, primary care, women's health, cardiovascular diagnostics, point-of-care, and portable handheld devices, in addition to products supporting surgical visualization and guidance. The Patient Care Solutions segment is dedicated to providing essential medical devices, consumable products, services, and digital platforms. Its portfolio encompasses patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal-infant care products. The Pharmaceutical Diagnostics segment supplies specialized diagnostic agents to the radiology and nuclear medicine industries. These include contrast media pharmaceuticals, administered to patients prior to scans like CT, angiography, X-ray, and MR, to enhance the visibility of internal tissues and structures. It also offers molecular imaging agents, or radiopharmaceuticals – molecular tracers labeled with radioisotopes – injected into patients for advanced diagnostic imaging applications such as Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and specific ultrasound procedures. Established in 2022, GE HealthCare Technologies Inc. maintains its corporate headquarters in Chicago, Illinois.
Prix de l'action
$69.86
Dernière synchronisation: 2026-10-20
Capitalisation boursière
$31.56B
Changement (1 jour)
0.15%
Changement (1 an)
-8.19%
Pays
US
Échange GE HealthCare Technologies Inc. (GEHC)
Catégorie
Healthcare
Ratio P/E pour GE HealthCare Technologies Inc. (GEHC)
Ratio P/E au October 2026 TTM : 19.68
Selon les derniers rapports financiers et le cours de l'action de GE HealthCare Technologies Inc., le ratio P/E actuel (TTM) est de 19.68. À la fin de l’année 2024, le P/E de l’entreprise était de 17.89.
Historique du ratio P/E pour GE HealthCare Technologies Inc. de 2019 à 2026
Ratio P/E à la fin de chaque année
| Année | Ratio P/E | Changez |
|---|---|---|
| 2026 (TTM) | 19.68 | -11.73% |
| 2025 | 22.29 | 24.60% |
| 2024 | 17.89 | -20.27% |
| 2023 | 22.44 | 62.22% |
| 2022 | 13.83 | 13.91% |
| 2021 | 12.14 | 516.21% |
| 2020 | 1.97 | -88.99% |
| 2019 | 17.90 | 0.00% |
Ratio P/E pour des entreprises similaires ou concurrentes
| Entreprise | P/E Ratio | Différence du P/E Ratio | Pays |
|---|---|---|---|
| 64.40 | 227.32% |
AU
|
|
| 44.30 | 125.16% |
US
|
|
| -47.78 | -342.82% |
US
|
|
| -123.90 | -729.71% |
US
|
|
| - | - |
US
|
Comment lire un P/E ratio ?
Le ratio Prix/Bénéfice (P/E Ratio) mesure la relation entre le cours de l'action d'une entreprise et ses bénéfices par action.
Un P/E bas mais positif indique une entreprise qui génère des bénéfices élevés par rapport à sa valorisation et qui pourrait être sous-évaluée. Un P/E négatif élevé (proche de 0) indique des pertes importantes.
Les entreprises avec un P/E supérieur à 30 ou négatif sont généralement considérées comme des "actions de croissance", ce qui signifie que les investisseurs s'attendent à ce qu'elles se développent ou deviennent rentables.
Les entreprises avec un P/E positif inférieur à 10 sont généralement considérées comme des "actions de valeur", car elles sont déjà très rentables mais avec peu de potentiel de croissance.